Cargando…

Modeling Parkinson’s Disease in C. elegans

Parkinson’s disease (PD) is an adult onset neurodegenerative disease that is characterized by selective degeneration of neurons primarily in the substantia nigra. At present, the pathogenesis of PD is incompletely understood and there are no neuroprotective treatments available. Accurate animal mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Jason F., Van Raamsdonk, Jeremy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836411/ https://www.ncbi.nlm.nih.gov/pubmed/29480229 http://dx.doi.org/10.3233/JPD-171258

Ejemplares similares

Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models
por: Cooper, Jason F, et al.
Publicado: (2015)

Targeting Mitochondrial Network Disorganization is Protective in C. elegans Models of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2021)

Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson’s disease models
por: Cooper, Jason F., et al.
Publicado: (2017)

Effect of DMSO on lifespan and physiology in C. elegans : Implications for use of DMSO as a solvent for compound delivery
por: AlOkda, Abdelrahman, et al.
Publicado: (2022)

Deletion of the Mitochondrial Superoxide Dismutase sod-2 Extends Lifespan in Caenorhabditis elegans
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2009)

Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson’s Disease
por: Gaeta, Anthony L., et al.
Publicado: (2019)

Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson’s disease
por: Senchuk, Megan M., et al.
Publicado: (2021)

Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models
por: Maulik, Malabika, et al.
Publicado: (2017)

Differential effect of Ayurvedic nootropics on C. elegans models of Parkinson’s disease
por: Anjaneyulu, Jalagam, et al.
Publicado: (2020)

Oxidative Stress Mechanisms Underlying Parkinson’s Disease-Associated Neurodegeneration in C. elegans
por: Chakraborty, Sudipta, et al.
Publicado: (2013)

Automated phenotyping and lifespan assessment of a C. elegans model of Parkinson’s disease
por: Kim, Minwook, et al.
Publicado: (2020)

Assessment of dopaminergic neuron degeneration in a C. elegans model of Parkinson’s disease
por: Palikaras, Konstantinos, et al.
Publicado: (2022)

Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein
por: Tyson, Trevor, et al.
Publicado: (2017)

Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
por: Liu, Jinghua, et al.
Publicado: (2015)

Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in C. elegans Model of Parkinson’s Disease
por: Chalorak, Pawanrat, et al.
Publicado: (2021)

Evolutionarily Conserved Role of Thioredoxin Systems in Determining Longevity
por: AlOkda, Abdelrahman, et al.
Publicado: (2023)

Using a Caenorhabditis elegans Parkinson’s Disease Model to Assess Disease Progression and Therapy Efficiency
por: Hughes, Samantha, et al.
Publicado: (2022)

Healthspan Enhancement by Olive Polyphenols in C. elegans Wild Type and Parkinson’s Models
por: Di Rosa, Gabriele, et al.
Publicado: (2020)

Age-Dependence and Aging-Dependence: Neuronal Loss and Lifespan in a C. elegans Model of Parkinson’s Disease
por: Apfeld, Javier, et al.
Publicado: (2017)

The C. elegans model in toxicity testing
por: Hunt, Piper Reid
Publicado: (2016)

Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in C. elegans and Cellular Models of Parkinson's Disease
por: Long, Tao, et al.
Publicado: (2022)

Swimming exercise reduces native ⍺-synuclein protein species in a transgenic C. elegans model of Parkinson’s disease.
por: Schmidt, Minna Y., et al.
Publicado: (2021)

Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease
por: Sanguanphun, Tanatcha, et al.
Publicado: (2023)

GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson’s disease
por: McIntyre, Lauren M., et al.
Publicado: (2022)

High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates
por: Sohrabi, Salman, et al.
Publicado: (2021)

An Environmental Contributor to Parkinson’s Disease Causes a Hormetic Lifespan Effect in C. elegans
por: Thies, Jennifer, et al.
Publicado: (2021)

An Environmental Contributor to Parkinson’s Disease Causes a Hormetic Lifespan Effect in C. elegans
por: Thies, Jennifer, et al.
Publicado: (2021)

Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson’s Disease
por: Tsai, Chia-Wen, et al.
Publicado: (2018)

Modelling the functional genomics of Parkinson’s disease in Caenorhabditis elegans: LRRK2 and beyond
por: Chandler, Rachael J., et al.
Publicado: (2021)

Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson’s Disease Models of Caenorhabditis elegans
por: He, Li, et al.
Publicado: (2022)

Modeling Alzheimer’s Disease in Caenorhabditis elegans
por: Alvarez, Javier, et al.
Publicado: (2022)

No Country for Old Worms: A Systematic Review of the Application of C. elegans to Investigate a Bacterial Source of Environmental Neurotoxicity in Parkinson’s Disease
por: Caldwell, Kim A., et al.
Publicado: (2018)

Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson’s models
por: Kim, Hanna, et al.
Publicado: (2018)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
por: Chege, Patricia M., et al.
Publicado: (2014)

Sirtuins and Autophagy in Age-Associated Neurodegenerative Diseases: Lessons from the C. elegans Model
por: Naseer, Anam, et al.
Publicado: (2021)

Levels and location are crucial in determining the effect of ROS on lifespan
por: Van Raamsdonk, Jeremy Michael
Publicado: (2015)

Editorial: C. elegans as an emerging model of pharmacological innovation
por: Huang, Zebo, et al.
Publicado: (2022)

A C. elegans model to study human metabolic regulation
por: Hashmi, Sarwar, et al.
Publicado: (2013)

Activation of DAF-16/FOXO by reactive oxygen species contributes to longevity in long-lived mitochondrial mutants in Caenorhabditis elegans
por: Senchuk, Megan M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8caju7ocloknahf2bdjek4agtk